Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.57 |
| ▸ | CES2 | O00748 | 2/20 | 0.42 |
| ▸ | CES1 | P23141 | 2/20 | 0.42 |
| ▸ | ELANE | P08246 | 1/20 | 0.39 |
| ▸ | EGFR | P00533 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.38 |
| ▸ | TUBB4A | P04350 | 2/20 | 0.38 |
| ▸ | TUBB | P07437 | 2/20 | 0.38 |
| ▸ | TUBA3C | P0DPH7 | 2/20 | 0.38 |
| ▸ | TUBA1B | P68363 | 2/20 | 0.38 |
| ▸ | TUBA4A | P68366 | 2/20 | 0.38 |
| ▸ | TUBB4B | P68371 | 2/20 | 0.38 |
| ▸ | TUBB3 | Q13509 | 2/20 | 0.38 |
| ▸ | TUBB2A | Q13885 | 2/20 | 0.38 |
| ▸ | TUBB8 | Q3ZCM7 | 2/20 | 0.38 |
| ▸ | TUBA3E | Q6PEY2 | 2/20 | 0.38 |
| ▸ | TUBA1A | Q71U36 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17629458 | 1.00 | LMNA (0.58) | LMNATDP1CES2CES1ELANE | |
| SCHEMBL1171617 | 1.00 | LMNA (0.58) | LMNATDP1CES2CES1ELANE | |
| SCHEMBL872839 | 1.00 | LMNA (0.58) | LMNATDP1CES2CES1ELANE | |
| Alcohol SCHEMBL3314314 | 0.98 | LMNA (0.57) | LMNATDP1CES2CES1ELANE | |
| SCHEMBL11783451 | 0.98 | TDP1 (0.59) | LMNATDP1CES2CES1EGFR | |
| SCHEMBL12291966 | 0.95 | LMNA (0.51) | LMNATDP1CES2CES1ELANE | |
| Benzyl Alcohol SCHEMBL28201687 | 0.92 | LMNA (0.51) | LMNATDP1CES2CES1MEN1 | |
| SCHEMBL30439628 | 0.91 | LMNA (0.64) | LMNATDP1CES2CES1EGFR | |
| SCHEMBL30439792 | 0.89 | TDP1 (0.65) | LMNATDP1CES2CES1EGFR | |
| SCHEMBL8741682 | 0.89 | LMNA (0.62) | LMNATDP1CES2CES1EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117503637-A | Composition for caring and relieving skin barrier, preparation method and application | 露乐健康科技股份有限公司 | 2024-02-06 | — | — | CN | claimed |
| CN-115466505-B | Silicon PU plastic material | 邯郸市爱尚体育科技有限公司 | 2024-01-12 | — | — | CN | claimed |
| CN-116782794-A | Dispensing package and method for controlled delivery of adhesive compositions | 宝洁公司 | 2023-09-19 | — | — | CN | claimed |
| CN-116270278-A | Composition for caring and relieving skin barrier, preparation method and application | 露乐健康科技股份有限公司 | 2023-06-23 | — | — | CN | claimed |
| CN-115876897-A | Method for simultaneously detecting multiple limited perfumes in cosmetics | 汕头海关技术中心 | 2023-03-31 | — | — | CN | claimed |
| CN-115466505-A | Nano water-based silicon PU plastic material | 邯郸市爱尚体育科技有限公司 | 2022-12-13 | — | — | CN | claimed |
| CN-115154377-A | Application of cedar bud extract in reducing essence irritation of infant skin care products and cedar bud extract skin care composition | 露乐健康科技股份有限公司 | 2022-10-11 | — | — | CN | claimed |
| CN-110179172-B | Consumable for an aerosol-generating device | 菲利普莫里斯生产公司 | 2022-06-24 | — | — | CN | claimed |
| US-8592621-B2 | Precursor compounds of sweet taste receptor antagonists for the prevention or treatment of disease | SYMRISE AG (DE) | 2013-11-26 | — | — | US | claimed |
| WO-2011061719-A1 | METHOD FOR FORMULATING PERFUME COMPOSITIONS HAVING HIGH LEVELS OF NATURAL INGREDIENTS AND NO DECLARED ALLERGENS, AND PERFUME COMPOSITION OBTAINED BY MEANS OF SUCH A METHOD | DANILA NICOLAS (FR) | 2011-05-26 | — | — | WO | claimed |
| US-20110045069-A1 | PRECURSOR COMPOUNDS OF SWEET TASTE RECEPTOR ANTAGONISTS FOR THE PREVENTION OR TREATMENT OF DISEASE | SYMRISE GMBH CO. KG (DE) | 2011-02-24 | — | — | US | claimed |
| WO-2025070466-A1 | SEAMLESS CAPSULE FOR ORAL CAVITY | 森下仁丹株式会社 | 2025-04-03 | — | — | WO | disclosed |
| CN-119235709-A | Composition for caring and relieving sensitive skin and application of composition in cosmetics | 露乐健康科技股份有限公司 | 2025-01-03 | — | — | CN | disclosed |
| CN-119235708-A | Inula flower extract, preparation method thereof and cosmetic composition | 太和康美(北京)中医研究院有限公司 | 2025-01-03 | — | — | CN | disclosed |
| CN-118518772-A | Method for detecting 26 sensitization essences in disposable sanitary products | 浙江方圆检测集团股份有限公司 | 2024-08-20 | — | — | CN | disclosed |
| US-20060292097-A1 | Fragrance compositions comprising benzo[4,5]thieno{3,2-b]pyran-2-one | FLEXITRAL, INC. | 2006-12-28 | — | — | US | disclosed |
| EP-1705171-A1 | Improved aromachemicals | Flexitral, Inc. (US) | 2006-09-27 | — | — | EP | disclosed |
| US-20060094640-A1 | Aromachemicals | FLEXITRAL, INC. | 2006-05-04 | — | — | US | disclosed |
| US-20050119156-A1 | Aromachemicals | FLEXITRAL, INC. | 2005-06-02 | — | — | US | disclosed |
| US-20050096852-A1 | Method for increasing the stability and intensity of odorant molecules | FLEXITRAL, INC. | 2005-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060292097-A1 | Fragrance compositions comprising benzo[4,5]thieno{3,2-b]pyran-2-one | TAS2R5, TRPA1, TAS2R4 | LMNA 3497/4885TDP1 2191/4885CES2 931/4885 |
| US-20110045069-A1 | PRECURSOR COMPOUNDS OF SWEET TASTE RECEPTOR ANTAGONISTS FOR THE PREVENTION OR TREATMENT OF DISEASE | TAS1R2, TAS2R5, TAS2R1 | LMNA 3996/4885TDP1 4364/4885CES2 3237/4885 |
| US-20050096852-A1 | Method for increasing the stability and intensity of odorant molecules | OR51E2, OR10J3, ZKSCAN2 | LMNA 4879/4885TDP1 4773/4885CES2 4666/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.